|
|
||||||||
Dengue infections were prospectively studied among 4- to 16-year-old students at a Bangkok school. Blood samples were obtained from 1,757 students in June 1980, before the dengue season, and in January 1981, after the season, and tested for dengue antibodies by the hemagglutination inhibition method. Classrooms were monitored daily for school absences. Fifty percent of the children had antibodies to, and were presumably immune to, at least 1 dengue serotype by the age of 7 years. Most (90/103, 87%) students who became infected by dengue viruses during the study period were either asymptomatic or minimally symptomatic (absent only 1 day). Most (7/13, 53%) of the symptomatic dengue infections (absent with fever for
2 days) were clinically recognized as cases of dengue hemorrhagic fever which required hospitalization. None of 47 primary dengue infections required hospitalization, whereas 7 of 56 secondary infections did (P = 0.012). Preexistent dengue immunity, as detected by conventional serologic techniques, was a significant (odds ratio
6.5) risk factor for development of dengue hemorrhagic fever.
Accepted for publication July 30, 1987.
This article has been cited by other articles:
![]() |
P. F. Wright, A. P. Durbin, S. S. Whitehead, M. R. Ikizler, S. Henderson, J. E. Blaney, B. Thumar, S. Ankrah, M. T. Rock, B. A. McKinney, et al. Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4{Delta}30-4995 in Healthy Adult Volunteers Am J Trop Med Hyg, November 1, 2009; 81(5): 834 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Recker, K. B. Blyuss, C. P. Simmons, T. T. Hien, B. Wills, J. Farrar, and S. Gupta Immunological serotype interactions and their effect on the epidemiological pattern of dengue Proc R Soc B, July 22, 2009; 276(1667): 2541 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kuan, A. Gordon, W. Aviles, O. Ortega, S. N. Hammond, D. Elizondo, A. Nunez, J. Coloma, A. Balmaseda, and E. Harris The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases Am. J. Epidemiol., July 1, 2009; 170(1): 120 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Thibodeaux and J. T. Roehrig Development of a Human-Murine Chimeric Immunoglobulin M Antibody for Use in the Serological Detection of Human Flavivirus Antibodies Clin. Vaccine Immunol., May 1, 2009; 16(5): 679 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. McArthur, A. P. Durbin, J. A. Marron, K. A. Wanionek, B. Thumar, D. J. Pierro, A. C. Schmidt, J. E. Blaney Jr, B. R. Murphy, and S. S. Whitehead Phase I Clinical Evaluation of rDEN4{Delta}30-200,201: A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity Am J Trop Med Hyg, November 1, 2008; 79(5): 678 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Chen, S.-R. Lin, H.-F. Liu, C.-C. King, S.-C. Hsieh, and W.-K. Wang Evolution of Dengue Virus Type 2 during Two Consecutive Outbreaks with an Increase in Severity in Southern Taiwan in 2001-2002 Am J Trop Med Hyg, October 1, 2008; 79(4): 495 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Kan, P.-F. Lee, T.-H. Wen, D.-Y. Chao, M.-H. Wu, N. H. Lin, S. Y.-J. Huang, C.-S. Shang, I-C. Fan, P.-Y. Shu, et al. Two Clustering Diffusion Patterns Identified from the 2001-2003 Dengue Epidemic, Kaohsiung, Taiwan Am J Trop Med Hyg, September 1, 2008; 79(3): 344 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lai, W.-Y. Tsai, S.-R. Lin, C.-L. Kao, H.-P. Hu, C.-C. King, H.-C. Wu, G.-J. Chang, and W.-K. Wang Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II J. Virol., July 1, 2008; 82(13): 6631 - 6643. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boonnak, B. M. Slike, T. H. Burgess, R. M. Mason, S.-J. Wu, P. Sun, K. Porter, I. F. Rudiman, D. Yuwono, P. Puthavathana, et al. Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection J. Virol., April 15, 2008; 82(8): 3939 - 3951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Noisakran and G. C. Perng Alternate Hypothesis on the Pathogenesis of Dengue Hemorrhagic Fever (DHF)/Dengue Shock Syndrome (DSS) in Dengue Virus Infection Experimental Biology and Medicine, April 1, 2008; 233(4): 401 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Cordeiro, A. M. Silva, C. A. A. Brito, E. J. M. Nascimento, M. C. F. Magalhaes, G. F. Guimaraes, N. Lucena-Silva, E. M. F. de Carvalho, and E. T. A. Marques Jr Characterization of a Dengue Patient Cohort in Recife, Brazil Am J Trop Med Hyg, December 1, 2007; 77(6): 1128 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Huang, T.-L. Liao, S.-F. Chang, C.-L. Su, L.-J. Chien, Y.-C. Kuo, C.-F. Yang, C.-C. Lin, and P.-Y. Shu Laboratory-based Dengue Surveillance in Taiwan, 2005: A Molecular Epidemiologic Study Am J Trop Med Hyg, November 1, 2007; 77(5): 903 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Gibbons, S. Kalanarooj, R. G. Jarman, A. Nisalak, D. W. Vaughn, T. P. Endy, M. P. Mammen Jr, and A. Srikiatkhachorn Analysis of Repeat Hospital Admissions for Dengue to Estimate the Frequency of Third or Fourth Dengue Infections Resulting in Admissions and Dengue Hemorrhagic Fever, and Serotype Sequences Am J Trop Med Hyg, November 1, 2007; 77(5): 910 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Wang, S.-F. Liu, S.-C. Liao, I.-K. Lee, J.-W. Liu, A.-S. Lin, C.-C. Wu, Y.-H. Chung, and M.-C. Lin Acute Respiratory Failure in Adult Patients with Dengue Virus Infection Am J Trop Med Hyg, July 1, 2007; 77(1): 151 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Srikiatkhachorn, C. Ajariyakhajorn, T. P. Endy, S. Kalayanarooj, D. H. Libraty, S. Green, F. A. Ennis, and A. L. Rothman Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever J. Virol., February 15, 2007; 81(4): 1592 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. ALVAREZ, R. RODRIGUEZ-ROCHE, L. BERNARDO, S. VAZQUEZ, L. MORIER, D. GONZALEZ, O. CASTRO, G. KOURI, S. B. HALSTEAD, and M. G. GUZMAN DENGUE HEMORRHAGIC FEVER CAUSED BY SEQUENTIAL DENGUE 1-3 VIRUS INFECTIONS OVER A LONG TIME INTERVAL: HAVANA EPIDEMIC, 2001-2002 Am J Trop Med Hyg, December 1, 2006; 75(6): 1113 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Clyde, J. L. Kyle, and E. Harris Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis J. Virol., December 1, 2006; 80(23): 11418 - 11431. [Full Text] [PDF] |
||||
![]() |
P. Sun, C. M. Celluzzi, M. Marovich, H. Subramanian, M. Eller, S. Widjaja, D. Palmer, K. Porter, W. Sun, and T. Burgess CD40 Ligand Enhances Dengue Viral Infection of Dendritic Cells: A Possible Mechanism for T Cell-Mediated Immunopathology J. Immunol., November 1, 2006; 177(9): 6497 - 6503. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Wearing and P. Rohani Ecological and immunological determinants of dengue epidemics PNAS, August 1, 2006; 103(31): 11802 - 11807. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhang, M. P. Mammen Jr, P. Chinnawirotpisan, C. Klungthong, P. Rodpradit, A. Nisalak, D. W. Vaughn, S. Nimmannitya, S. Kalayanarooj, and E. C. Holmes Structure and age of genetic diversity of dengue virus type 2 in Thailand. J. Gen. Virol., April 1, 2006; 87(Pt 4): 873 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Huang, Y.-C. Yang, Y.-S. Lin, J.-H. Huang, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, and H.-Y. Lei The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J. Immunol., March 1, 2006; 176(5): 2825 - 2832. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. T. Cummings, I. B. Schwartz, L. Billings, L. B. Shaw, and D. S. Burke Dynamic effects of antibody-dependent enhancement on the fitness of viruses PNAS, October 18, 2005; 102(42): 15259 - 15264. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tassaneetrithep, T. H. Burgess, A. Granelli-Piperno, C. Trumpfheller, J. Finke, W. Sun, M. A. Eller, K. Pattanapanyasat, S. Sarasombath, D. L. Birx, et al. DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells J. Exp. Med., April 7, 2003; 197(7): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kaufman and I. B. Lamster THE DIAGNOSTIC APPLICATIONS OF SALIVA-- A REVIEW Critical Reviews in Oral Biology & Medicine, March 1, 2002; 13(2): 197 - 212. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |